Clinical Trials Logo
NCT number NCT03498183
Study type Interventional
Source Nantes University Hospital
Contact Eric Mirallié, MD
Email eric/mirallie@chu-nantes.fr
Status Not yet recruiting
Phase Phase 2/Phase 3
Start date July 1, 2018
Completion date July 1, 2021

Clinical Trial Summary

The main objective of the study is to show that the addition of ultrasonography to the dual tracer scintigraphy MIBI-Tc99m/Iodine-123 will increase (at least +5%) the negative predictive value compared to the dual tracer scintigraphy alone in detection of malignancy in thyroid nodules ≥15 mm classified as Bethesda III-IV on cytology.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms